Demant A/s · OMXCOP:DEMANT
Demant A/s — AudiologyNOW! 2017
58 slides from Demant A/s's conference presentation, Apr 6, 2017
Slide 1: Management Presentation AudiologyNOW! 2017
Management Presentation AudiologyNOW! 2017 6 April 2017 Søren Nielsen, President & CEO Jes Olsen, President of Oticon Medical
Slide 2: Agenda
Agenda • Management • General update • Hearing Devices • Hearing Implants • Diagnostic Instruments • Q&A 2
Slide 3: Management
a William Demant , Management
Slide 4: Søren Nielsen
Søren Nielsen President & CEO of William Demant Holding as of 1 April 2017 • Executive Board consists of Søren Nielsen and René Schneider (CFO) • Continues as President of Oticon Curriculum vitae Board positions • Born in 1970 • Sennheiser Communications • M.Sc. in Industrial Management and Product
Slide 5: Executive Board and Management
Executive Board and Management High seniority and lots of industry insights .... Søren Nielsen René Schneider President & CEO CFO Arne Boye Nielsen Niels Wagner Svend Thomsen Diagnostics Retail Finance 5
Slide 6: General update
a William Demant , General update
Slide 7: Highlights 2016
Highlights 2016 13% Strong revenue growth of 13% with organic growth of 6% Oticon Opn and retail activities drove strong growth US retail and Hearing Implants performed below expectations Growth in Diagnostic Instruments in line with estimated market growth Execution on strategic initiatives on trac
Slide 8: Outlook 2017
Outlook 2017 We expect a unit growth rate of 4-6% with a low, single-digit decline in the market’s average wholesale price due to competition and possible mix effects. In terms of value, we thus expect the wholesale market to grow by 1-3% in 2017 as was also the case in 2016. We expect to generate g
Slide 9: Hearing Devices
Hearing Devices
Slide 10: Oticon Opn The open sound paradigm
Oticon Opn™ The open sound paradigm continues to expand
Slide 11: Opening up the world
Opening up the world 11 Oticon Opn - The open sound paradigm continues to expand
Slide 12: The Open Sound Experience
The Open Sound Experience The result of a winning formula of Oticon technology The open sound experience OpenSound Navigator™ Spatial Sound™ LX
Slide 13: BrainHearing support
BrainHearing™ Open access support In 5 key areas 1 to all speakers Rapid 2 noise reduction 3 Localisation of sounds 4 Speech clarity 5 A personalised listening experience 13 Oticon Opn - The open sound paradigm continues to expand
Slide 14: Opn is now rechargeable!
Opn™ is now rechargeable! 14 Oticon Opn - The open sound paradigm continues to expand
Slide 15: Opn miniRITE – Convenient and Easy to Use
Opn miniRITE – Convenient and Easy to Use Battery life for a full day’s use CONVENIENT EASY TO USE REASSURING UPGRADABLE 15 Oticon Opn - The open sound paradigm continues to expand
Slide 16: Opn miniRITE – A Powerful Combination
Opn miniRITE – A Powerful Combination The only rechargeable hearing aid with an open sound experience The world’s first rechargeable hearing aid with 2.4 GHz direct streaming Existing Opn install-base can be retrofitted to become rechargeable Hybrid battery technology for maximum flexibility – power
Slide 17: Introducing new styles
Introducing new styles Even more open sound opportunities miniRITE miniRITE-T BTE13 PP 17 Oticon Opn - The open sound paradigm continues to expand
Slide 18: miniRITE-T
miniRITE-T Brand new design Small and discreet 7 colours IP 68 miniFit receivers Double push button miniFit earpieces T-coil Battery 312 18 Oticon Opn - The open sound paradigm continues to expand
Slide 19: Open up to more power
Open up to more power Power options for miniRITE and miniRITE-T Speaker 100 Power Flex mould 19 Oticon Opn - The open sound paradigm continues to expand
Slide 20: Introducing BTE13 PP
Introducing BTE13 PP The perfect balance between size, user friendliness and power 20 Oticon Opn - The open sound paradigm continues to expand
Slide 21: BTE13 PP
BTE13 PP A powerful offering for the power user T-coil Hook Double push button Two colour LED light Locator nub miniFit earpieces for Corda miniFit Power Battery 13 Corda miniFit Power 7 colours IP 68 21 Oticon Opn - The open sound paradigm continues to expand
Slide 22: Oticon Opn with Speech Rescue
Oticon Opn with Speech Rescue™ Open sound with high-frequency audibility Also available to existing Opn users 22 Oticon Opn - The open sound paradigm continues to expand
Slide 23: Frequency lowering with Speech Rescue
Frequency lowering with Speech Rescue™ Making increased sounds available -10 Speech has less energy at high 0 10 frequencies 20 f th Hearing loss is often larger at high 30 z v s Hearing Level, dB HL p frequencies 40 j md b n i a o r h g ch sh k ng 50 e l By taking the high frequency energy an
Slide 24: Speech Rescue LX and other features
Speech Rescue LX and other features A three-step process to deliver the best audibility Remove noise, Make increased Amplify clean signal sounds available (frequency lowering) Step 1 Step 2 Step 3 360° OpenSound Speech Speech Navigator™ Rescue LX Guard™ LX sound Hearing aid processing Speech Rescue
Slide 25: Speech Rescue with OpenSound Navigator
Speech Rescue with OpenSound Navigator guests el - bow each other over the smoked sal mon Time/frequency representation of speech in noise 8300 5950 4700 3650 2800 channels 2200 16Frequency [Hz] 1700 1400 1250 1100 950 800 650 450 300 100 0 0.5 1 1.5 2 2.5 Time [seconds] 25 Oticon Opn - The open s
Slide 26: Speech Rescue with OpenSound Navigator
Speech Rescue with OpenSound Navigator Analysis and subsequent labelling of speech and noise in OpenSound Navigator 16 channels 26 Oticon Opn - The open sound paradigm continues to expand
Slide 27: Speech Rescue with OpenSound Navigator
Speech Rescue with OpenSound Navigator guests el - bow each other over the smoked sal mon Speech in noise signal after removal of detected noise 8300 5950 4700 3650 2800 channels 2200 16Frequency [Hz] 1700 1400 1250 1100 950 800 650 450 300 100 0 0.5 1 1.5 2 2.5 Time [seconds] 27 Oticon Opn - The
Slide 28: Speech Rescue with OpenSound Navigator
Speech Rescue with OpenSound Navigator guests el - bow each other over the smoked sal mon Comparison to speech in noise signal without OpenSound Navigator 8300 5950 4700 3650 2800 channels 2200 16Frequency [Hz] 1700 1400 1250 1100 950 800 650 450 300 100 0 0.5 1 1.5 2 2.5 Time [seconds] 28 Oticon
Slide 29: Oticon Opn with Tinnitus SoundSupport
Oticon Opn with Tinnitus SoundSupport™ A winning combination of tinnitus relief and open sound Also available to existing Opn users 29 Oticon Opn - The open sound paradigm continues to expand
Slide 30: The complete tinnitus solution
The complete tinnitus solution What makes the Oticon solution unique Tinnitus SoundSupport TM Opn combination device with Tinnitus SoundSupport and OpenSound Navigator OpenSound Navigator TM Tinnitus Easy fitting Treatment Intuitive and easy for Professionals fitting tool in Genie 2 Counselling and
Slide 31: Opn – now also for teens
Opn – now also for teens Introducing Desired Sensation Level (DSL) rationale for fitting of children and teens Fits teens with assurance that best practice guidelines are followed Confident listening both in classrooms and in complex listening environments common in a teen’s life 31 Oticon Opn
Slide 32: Positive product mix effects from Opn
Positive product mix effects from Opn Opn 1 still leads positive product mix effect Very positive momentum continues Added to VA contract in November 2016 Still best-selling Opn product Opn 2 and 3 also having positive product mix effect Launched in the upper mid-priced and the mid-price
Slide 33: The open sound paradigm continues to expand
The open sound paradigm continues to expand Now addressing even larger part of the market with our open sound paradigm Opn is now a rechargeable solution, including current install-base BTE13 PP addressing severe to profound hearing losses Addressing more types of hearing loss profiles with
Slide 34: Bernafon and Sonic
Bernafon and Sonic • Our Bernafon and Sonic brands have driven high volumes • Weakening of sales to Costco for Bernafon • Both brands will launch new products by the end of Q2 2017 • Will be available in different styles and in three price/performance categories
Slide 35: Selected Topics
a William Demant , Selected Topics
Slide 36: Update on US OTC
Update on US OTC • ”Over-the-Counter Hearing Aid Act of 2017” (OTC bill) introduced in both chambers of US Congress on 21 March 2017 • There will be a workshop on Hearing Health and Technology on 18 April 2017 hosted by the Federal Trade Commission (FTC) • We continue to believe that safety and effi
Slide 37: Remote assistance/fitting
Remote assistance/fitting Connected hearing aids enabling a closer relationship between Hearing Care Professionals (HCP) and end-users • Remote assistance may come in different Level of forms varying with the type and level of remote assistance Feature Offline Real-time • Support • Professional invo
Slide 38: Hearing Implants
aN Hearing Implants
Slide 39: Ponto 3 – the world's most powerful abutment-level processors
Ponto 3 – the world’s most powerful family of abutment-level processors 39
Slide 40: Ponto 3 – the definition of power
Ponto 3 – the definition of power 1st wave launch in October 2016, Super Power in mid-December Continued strong momentum following the launch Market being redefined because of Super Power and the strong focus on the need for ”direct drive” and more power for best possible outcomes 40
Slide 41: Direct transmission continues to be the golden standard
Direct transmission continues to be the golden standard in bone-anchored hearing systems •Paediatrics* and adults Direct drive Ponto •Conductive and mixed •Single-sided deafness Transcutaneous, •Adults magnet •Conductive Skin drive •Paediatrics before surgery is an option and adults Headband or •Con
Slide 42: Neuro Cochlear Implant System
Neuro Cochlear Implant System Neuro One Neuro Zti Oticon Technology Inside Ultra Compact Design Powerful Inium platform The smallest surgical footprint Automatic environment detection Innovative materials Free focus directionality Ultra-thin Coordinated Adaptive Processing Powerful, Future Ready Tec
Slide 43: Neuro – Significant progress through excellent outcomes
Neuro – Significant progress through excellent outcomes Implanting in more than 80 centers and 18 countries – and growing France active from 1st of March 2017 Brazil active from April 2017 FDA trial started in January 2017 Important reference centers MHH Hannover, Germany Rigshospitalet, Denmark Lil
Slide 44: Neuro – A strong offering complemented by upcoming introductions
Neuro – A strong offering complemented by upcoming introductions Neuro offering Fair Good Excellent Implant size X Surgical aspects X Electrode insertion X Power efficiency X Stability X Audiological outcomes X BTE size (Neuro One) X X Upcoming product introductions BTE design and useability (Neuro
Slide 45: Comparative data: The latest CI sound processing technology
Comparative data: The latest CI sound processing technology, Bergeron et. al. (2014)* Comparative data between major CI manufacturers from Bergeron et. al. (2014)* Data collected with latest technology for all manufacturers Random comparable samples 10 OM/Neurelec subjects included for all condition
Slide 46: Significantly better results in noise
Significantly better results in noise - speech in noise Latest CI sound processing technology: In comparative data, Saphyr neo collection showed significantly better results in noise 10dB SNR than technology from manufacturers B and C* 46
Slide 47: Medizinische Hochschule Hannover – Study details
Medizinische Hochschule Hannover – Study details Modified from A. Büchner et al., 2017 Oticon Medical Scientific Meeting, KBN, Den. Neuro patients Matched control group 10 patients 174 patients from the MHH CI patient’s database matched for: Age: 64.6 years on average Long deprivation duration: 18.2
Slide 48: Medizinische Hochschule Hannover – Study results
Medizinische Hochschule Hannover – Study results 90 N = 480 80 Avg. duration of deafness 5.4y Newest generation implants 70 (Analysis from 2014) 60 N = 10 50 Avg. duration of deafness 18.2y Avg. age: 64.6y 40 Oticon Neuro Zti Implant 30 (January 2017) 20 N = 174 10 Avg. duration of deafness 17.4y Av
Slide 49: Completing the plan - creating the most attractive BTE and fitting software
Completing the plan - creating the most attractive BTE and fitting software ever 49
Slide 50: The short to medium term perspective
The short to medium term perspective What if the outcome data can be replicated for larger and diverse groups of patients? Speech in background noise is the holy grail in CI Speech in background noise is strongly related to listening effort and Brain Hearing For paediatrics listening effort is very
Slide 51: Diagnostic Instruments
Diagnostic Instruments a ———_
Slide 52: Diagnostic Instruments
Diagnostic Instruments • Multi-brand approach with wide range of audiological equipment products Audiometers Impedance Fitting ABR* OAE* VNG* *Note: ABR: Auditory Brainstem Response; OAE: Otoacoustic Emissions and VNG: Videonystagmography 52
Slide 53: New products from Grason-Stadler and Maico
New products from Grason-Stadler and Maico New touchTymp impedance product from New Pello diagnostic audiometer from Grason- Maico Stadler • Middle ear diagnostics product • Addressing the mid-level part of the • Complements current screening product audiometer market with additional advanced testin
Slide 54: Interacoustics – 50 years anniversary in 2017
Interacoustics – 50 years anniversary in 2017 Updated product portfolio within Video Nystamography (VNG) and Otoacoustic Emissions (OAE) • Micromedical VisualEyes 525 is a new • Otoread is a new portable OAE device innovative touch screen balance equipment • Optimized for accuracy and ease of use •
Slide 55: MedRx Tinnometer
MedRx Tinnometer Revolutionary new approach to tinnitus assessment • First solution of its kind on the market • Customized stimulus • Precise control of level, shape & frequency • Built-in tinnitus reports • Significantly reducing the time of performing a tinnitus assessment • Improved accuracy in t
Slide 56: A strong platform for future growth
A strong platform for future growth … and a vision to make a life-changing difference to people living with hearing loss 56
Slide 57: Q&A
Q&A
Slide 58: IR contacts
IR contacts Søren B. Andersson Vice President, Investor Relations Email: sba@demant.com Tel: +45 3913 8967 Mob: +45 5117 6657 Mathias Holten Møller Investor Relations Officer Email: msmo@demant.com Tel: +45 3913 8827 Mob: +45 2924 9407